Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

SETB. 2009; 43(2): 77-81


PTEN expression and its relationship with prognostic factors in gastric adenocarcinomas

Cumhur Selçuk Topal, Müberra Seğmen Yılmaz, Murat Hakan Karabulut, Dilek Yavuzer, Nimet Karadayı.




Abstract

Objective: PTEN (phosphatase and tensin) is an important molecular marker that works as a tumor supressor gene located on the 10th chromosome (10q23.3). In this retrospective study, PTEN expression and its relationship with prognostic parameters have been investigated.
Study design: Slides obtained from paraffine blocks of 60 gastric adenocarcinoma immunohistochemically stained with PTEN (Clone 28H6, Novocastra, UK).
Results: Statistically significant relationship was found between Lauren‘s classification, histologic grade and PTEN expression. But we were unable to show significant relationship with PTEN and vascular invasion, perineural invasion, lymph node metastasis, TNM (primary tumor, lymph node, distant metastasis) stage.
Conclusions: We found that PTEN expression loss is more prominent in the diffuse type carcinomas than the intestinal types and also there is a reverse correlation between histologic differentiation and PTEN loss. As a result PTEN expression was found to be related to malignant transformation, tumor progression and histologic grade.

Key words: PTEN, gastric adenocarcinoma






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.